Show results for
Refine by
Cell Therapy For Cellular Therapy Equipment Supplied In Singapore
2 equipment items found
Manufactured by:Mesoblast Ltd. based inMelbourne, AUSTRALIA
MPC-25-IC is Mesoblast’s Phase 2 product candidate for the treatment of acute myocardial infarction. This is the first clinical study to evaluate an allogeneic cellular therapy delivered by intracoronary infusion in patients who have suffered an acute myocardial ...
Manufactured by:Mesoblast Ltd. based inMelbourne, AUSTRALIA
Remestemcel-L is being developed for inflammatory diseases in children and adults including the treatment of acute graft versus host disease (aGVHD), a potentially life-threatening complication of an allogeneic bone marrow transplant (BMT). Currently, there are no products currently approved in the United States for treatment of steroid-refractory aGVHD in children under 12, and off-label options ...